Australia's most trusted
source of pharma news
Wednesday, 4 February 2026
Wednesday, 4 February 2026
Subscribe
Login
17 pharmas hunting expansions
There's a bumper line-up of companies looking to expand their medicines with new indications - including one therapy which could become one of the most expensive drugs in Australia.
Even better than semaglutide...
Novo may have outdone itself with a hyped combo outperforming its star T2 diabetes and obesity treatment in a head-to-head trial
TODAY
Aussies drive brain cancer drug
Canadian company partners with local researchers and oncologists for a world-first clinical trial in children and adolescents
TODAY
Restructure hits Aussie workforce
Business structure review hits the Australian team as company 'reshapes and redefines some employee roles'
3 February
$200M PBS market slashed in half
The government has cut the PBS list price of a major drug, following negotiations with the sponsor
3 February
Milestone PBAC victory finally lands
After a decade of wrangling, MSD has finally received a recommendation for its blockbuster drug Keytruda for multiple cancers
2 February
Best managed pharmas crowned
A ranking of companies by corporate effectiveness has revealed the pharmas that were best managed in 2025, amid a strong showing
2 February
Latest Jobs
Finance ManagerSenior Recruitment ConsultantRecruitment ConsultantDistribution and Warehouse TechnicianMedical AdvisorLogistics SpecialistHead of MedicalWarehouse Associate39 more...
Pharma in Focus Jobs
Marketing & Communications (2)
Sales & Customer Relations (16)
- Associate Business Development Director - Clinical Research, China - Shanghai, China
- Customer Service Representative - St Leonards
- Hospital Sales Representative - Melbourne
- Sales & Key Account Associate - Melbourne
- Senior Territory Sales Manager - Melbourne
- Customer Service Representative - Pemulwuy
- Inside Sales Specialist - Melbourne
- Key Account Manager - CNS - Sydney
- GP Sales Representative - Brisbane
- Pharmaceutical Sales Representative - Gold Coast
- Clinical Research, Business Development Manager - Shanghai, China
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
- Pharmaceutical Sales Representative - Sydney
- Customer Service Specialist - Frenchs Forest
- Specialist Account Manager - Sydney
- Key Account Manager - Sydney
Access & Reimbursement (1)
Clinical & Medical, R&D (7)
- Medical Advisor - Sydney
- Head of Medical - Sydney
- Associate Business Development Director - Clinical Research, China - Shanghai, China
- Senior Project Director - Clinical Research - Shanghai, China
- Clinical Research, Business Development Manager - Shanghai, China
- Site Medical Director - Sydney
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
Regulatory, Pharmacovigilance & QA (5)
- Senior Quality Assurance Associate - Melbourne
- Senior Regulatory Affairs Associate - Sydney
- Pharmacovigilance and Regulatory Specialist - Melbourne
- Senior Technical & Regulatory Associate - Sydney
- Senior Regulatory Affairs Associate - Sydney
Executive Roles (4)
- Associate Business Development Director - Clinical Research, China - Shanghai, China
- Senior Project Director - Clinical Research - Shanghai, China
- Site Medical Director - Sydney
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
Other (20)
- Finance Manager - Melbourne
- Senior Recruitment Consultant - Victoria
- Recruitment Consultant - Sydney
- Distribution and Warehouse Technician - Broadmeadows
- Logistics Specialist - Macquarie Park
- Warehouse Associate - Chatswood
- Chief Operating Officer - Sydney
- Chief Operating Officer - Sydney
- Dedicated Principal Agent - Pemulwuy
- Finance Administrator - Sydney
- Warehouse & Logistics Officer - Macquarie Park
- GP Rep Bundaberg Contract - Bundaberg
- Commercial Lead - Melbourne
- Commercial Lead - Melbourne
- Senior Payroll Officer - 41808-1 - Melbourne
- Materials Planner - North Ryde
- Senior Recruitment Consultant - Sydney
- Warehouse Coordinator - Alexandria
- HR Analyst (Workday Specialist) - Melbourne
- Senior Recruitment Consultant - Sydney
Aussies win global pharma grant
Selected from a tough field of more than 80 worldwide submissions, this joint initiative by two high-profile patient groups impressed
3 February
AZ signs monster obesity deal
The British giant has signed a deal with Chinese CSPC worth up to $18 billion, giving access to early-stage monthly injectables
3 February
Sandoz cracks blockbuster market
First competitor stepping into the top-earning space reveals the next steps to ensure uptake of the PBS-listed biosimilar
3 February
PBS spending hits 25-year low
Pfizer's pre-budget submission lifts the lid on practices used by the Govt that have pushed medicine funding into decline
2 February
Next-gen blockbuster hits PBS
With the first biosimilar of Bayer's Eylea also among a handful of the new additions to the scheme this month
2 February New to the PBS
TGA tick sets up PBAC win
Drug deferred by the PBAC last year pending TGA approval plus Seqirus buffs up Ferinject franchise with a new brand
2 February Approvals Action
And again: Aussie MD departs
The third ANZ Country Head departure this month has been announced with this leader promoted to a global role in the US
30 January
Next blockbuster wave looms
Find out which drugs are about to start their blockbuster run transforming treatment paradigms and passing US$1B in sales
30 January
Ex-Aussie GM's golden career run
ICYMI: Former Country Leader promoted, doubling his leadership territory plus the other most popular stories this week
30 January Your Week in 5 Minutes
FDA-approved gene therapy nears
A genetically modified therapy for bladder cancer already FDA approved could soon be studied in Aussie patients
30 January
TGA alert over AbbVie counterfeits
Company confirms products are fake with the regulator urging consumers to take extreme caution when buying medicines online
30 January
Another ANZ Country Head leaving
After four years in the top job, this Big Pharma leader has been promoted to a global role with the company already naming his successor
29 January
AZ scrambles for $100M market
Market threatened by early generic competition, with AstraZeneca petitioning a judge to block the PBS listing
29 January
Roche arrives late but with a bang
Although late to the party, Roche's investment in the obesity space has yielded a real challenger to its rivals but can it catch up?
29 January